Urology Annals
About UA | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionLogin 
Urology Annals
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 775   Home Print this page  Email this page Small font size Default font size Increase font size

Table of Contents
Year : 2016  |  Volume : 8  |  Issue : 3  |  Page : 360-362  

A case of Carney complex presenting as acute testicular pain

Department of Urology, Colchester Hospital University NHS Foundation Trust, Essex, CO4 5JL, United Kingdom

Date of Submission01-Nov-2015
Date of Acceptance14-Apr-2016
Date of Web Publication29-Jun-2016

Correspondence Address:
Adam Alleemudder
Department of Urology, Colchester Hospital University NHS Foundation Trust, Turner Road, Essex CO4 5JL
United Kingdom
Login to access the Email id

DOI: 10.4103/0974-7796.184887

PMID: 27453662

Rights and Permissions

We describe the case of a 7-year-old boy who presented with testicular pain but was found to have bilateral testicular lesions later confirmed as Sertoli cell tumors. Genetic testing confirmed a PRKAR1A gene mutation consistent with Carney complex, a rare genetic disorder characterized by skin lesions, myxomas, and multiple endocrine neoplasms. A review of the condition is made highlighting the association with testicular tumors, particularly of Sertoli cell origin.

Keywords: Carneys complex, multiple endocrine neoplasms, PRKAR1A gene, Sertoli cell tumor

How to cite this article:
Alleemudder A, Pillai R. A case of Carney complex presenting as acute testicular pain. Urol Ann 2016;8:360-2

How to cite this URL:
Alleemudder A, Pillai R. A case of Carney complex presenting as acute testicular pain. Urol Ann [serial online] 2016 [cited 2022 Jan 24];8:360-2. Available from: https://www.urologyannals.com/text.asp?2016/8/3/360/184887

   Introduction Top

Carneys complex is an extremely rare genetic disorder inherited by autosomal dominance or by sporadic de novo genetic defects. Over half of the cases are familial. At the last estimate there were only 750 patients worldwide with the condition. The most commonly found defect in two thirds of cases is mutation of the PRKAR1A tumor suppressor gene on Chromosome 17. It leads to a triad of manifestations namely pigmented lesions of the skin and mucosa, myxomas and multiple endocrine tumors. Although they only account for 1.5% of all testicular tumors, 40% of patients with this condition will develop large cell-calcifying Sertoli cell tumors, the majority of which have a low malignant potential.

   Case Report Top

We describe the case of a 7-year-old boy with no significant past medical or family history who initially presented as an emergency with acute left testicular pain and a scrotal exploration was performed. This demonstrated a normal untwisted left testis with a raised 1 cm paratesticular lesion of unknown significance lying between the posterior aspect of the testis and the body of the epididymis [Figure 1]. As there was no evidence of torsion, a decision was made to return the testis to the scrotum and a provisional diagnosis of epididymitis was made. An ultrasound scan after 2 weeks of antibiotics showed bilateral microcalcification and a 2 mm hypoechoic lesion in the right testis [Figure 2] in addition to the 1.4 cm left vascular paratesticular lesion [Figure 3]. The testicular tumor markers were all normal. He was referred to a tertiary care center where excision of the left-sided lesion and excisional biopsy of the right lesion confirmed benign bilateral Sertoli cell tumors. Closer physical examination later found precocious puberty and spotty freckles which raised suspicion that led to genetic testing and the subsequent diagnosis of Carneys complex (CNC).
Figure 1: Scrotal exploration revealed a normal testis with a 1 cm lesion between the testis and epididymis

Click here to view
Figure 2: Ultrasound showing micro calcification and a hypoechoeic lesion in the right testis

Click here to view
Figure 3: Vascular 1 cm left paratesticular mass shown on ultrasound

Click here to view

   Discussion Top

CNC is a rare genetic syndrome, first described in 1985, comprising pigmented skin and mucosal lesions, myxomas, and multiple mainly endocrine neoplasms.[1] The majority arise from autosomal dominant inheritance with a smaller number from sporadic de novo mutations. There are at least 750 patients known with the disease from a variety of ethnic backgrounds with women affected in two-thirds of cases.[2]

The most common genetic defect in over 70% is mutation of the PRKAR1A tumor suppressor gene located at 17q22-24 which encodes for the type 1α subunit of protein kinase A involved in the cAMP signaling pathway. Another mutation, which clinically manifests later in life, is found at the 2p16 region although the exact nature and function of this gene(s) is unknown.[2]

CNC is characterized by a varied list of manifestations and diagnosis is usually made in the second decade based on certain criteria [Table 1]. Once suspected, genetic testing for the affected gene is warranted using sequence or deletion/duplication analysis. The most common are cutaneous lentigines that develop around puberty on the face, genitals, mucosae and lips, and cardiac myxomas which are the principle cause of mortality in 50% through restriction of blood flow or generation of emboli. The most common endocrine neoplasm is primary pigmented nodular adrenocortical disease where the raised cortisol leads to Cushing's syndrome.
Table 1: Clinical features and diagnostic criteria of Carneys complex. There must be two of the major criteria confirmed by histology, imaging or biochemical testing or one major and one supplemental criteria

Click here to view

Testicular tumors affect 50% of patients, and the majority are large-cell calcifying Sertoli cell tumors (LCCSCT) with low malignant potential.[3] Other tumors of Sertoli cell origin include sclerosing, sex cord with annular tubules, and unspecified. Leydig cell tumors and adrenocortical rest tumors are rare.  Sertoli cells More Details play a role in structural support, in the differentiation of spermatocytes and secretion of anti-Mullerian hormone during early fetal life causing regression of the Mullerian ducts. LCCSCTs account for 1.5% of all testicular tumors and 40% occur as part of genetic syndromes.[4] The pathological production of aromatase leads to the peripheral conversion of testosterone to estradiol that causes gynecomastia and epiphyseal plate closure in long bones. It also causes precocious puberty through conversion of androstenedione to estrone which leads to increased androgen production. The tumors are often multicentric, bilateral, and contain microcalcifications in the shape of a Christmas tree pattern.[5] They tend to be asymptomatic unless macrocalcifications are present causing an overall increase in testicular size, which may obstruct the seminiferous tubules leading to infertility.

The management of CNC involves medical or surgical intervention for each specific complication or tumor; LCCSCTs causing precocious puberty, gynecomastia, or premature epiphyseal fusion usually requires medical therapy with aromatase inhibitors and/or surgery. The majority of LCCSCTs is benign though and can be managed conservatively with surveillance. Malignant LCCSCTs are found in 17% and are more common in older patients, especially when there is unilateral or unifocal disease, a large mitotic count, size larger than 4 cm or significant nuclear atypia.[4] CNC requires annual surveillance due to the high mortality and morbidity which includes echocardiography, hormonal assays for growth hormone, prolactin and insulin-like growth factor-1, pituitary magnetic resonance imaging, and ultrasound of the testis.

   Conclusion Top

This unusual case highlights the importance of following up cases initially suspected as epididymo-orchitis. An awareness of CNC in urology is important due to the risks of developing testicular tumors and infertility.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

   References Top

Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985;64:270-83.  Back to cited text no. 1
Correa R, Salpea P, Stratakis CA. Carney complex: An update. Eur J Endocrinol 2015;173:M85-97.  Back to cited text no. 2
Wilkes D, McDermott DA, Basson CT. Clinical phenotypes and molecular genetic mechanisms of Carney complex. Lancet Oncol 2005;6:501-8.  Back to cited text no. 3
Halat SK, Ponsky LE, MacLennan GT. Large cell calcifying Sertoli cell tumor of testis. J Urol 2007;177:2338.  Back to cited text no. 4
Premkumar A, Stratakis CA, Shawker TH, Papanicolaou DA, Chrousos GP. Testicular ultrasound in Carney complex: Report of three cases. J Clin Ultrasound 1997;25:211-4.  Back to cited text no. 5


  [Figure 1], [Figure 2], [Figure 3]

  [Table 1]

This article has been cited by
1 Dermatological and endocrine elements in Carney complex (Review)
Florica Sandru, Mihai Dumitrascu, Aida Petca, Mara Carsote, Razvan-Cosmin Petca, Diana Paun
Experimental and Therapeutic Medicine. 2021; 22(5)
[Pubmed] | [DOI]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
   Case Report
    Article Figures
    Article Tables

 Article Access Statistics
    PDF Downloaded253    
    Comments [Add]    
    Cited by others 1    

Recommend this journal